Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 361 - 375 of 453 items.
Health Canada will be updating its safety review of breast implants
AlertInformation update | 2019-02-12
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30
Health Canada warns that products sold by A1 Herbal Ayurvedic Clinic Ltd. may pose serious health risks
AlertPublic advisory | 2019-01-28
Unauthorized Panasilver product for children and adults may pose serious health risk
AlertPublic advisory | 2019-01-24
Health Canada encourages Canadians to report incidents involving medical devices to help strengthen patient safety
AlertInformation update | 2019-01-15
Health Canada safety review finds possible link between Fibristal and risk of liver injury
AlertInformation update | 2019-01-11
Health Canada warns consumers that Pace, promoted as an alcohol substitute, is unauthorized and may pose serious health risks
AlertPublic advisory | 2018-12-21
One lot of Equate brand Lens Care System and Multi-Purpose Solution voluntarily recalled because of a labelling error
AlertPublic advisory | 2018-12-21
Health Canada releases test results of certain sartan drugs
AlertInformation update | 2018-12-20
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
AlertHealth professional risk communication | 2018-12-20
Cannabis and Alcohol Use During the Holidays
AlertInformation update | 2018-12-17
Foreign Product Alert: Quizz Capsules by Trio Healthcare
AlertPublic advisory | 2018-12-14
Health products manufactured by Professional Botanicals Inc. may pose serious health risks
AlertPublic advisory | 2018-12-13